Chevy Chase Trust Holdings Inc. boosted its holdings in shares of Stryker Corporation (NYSE:SYK) by 4.5% in the third quarter, according to its most recent filing with the SEC. The firm owned 316,828 shares of the medical technology company’s stock after acquiring an additional 13,692 shares during the period. Chevy Chase Trust Holdings Inc. owned 0.08% of Stryker worth $44,996,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in SYK. Vanguard Group Inc. boosted its stake in Stryker by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock worth $3,341,643,000 after purchasing an additional 657,656 shares during the period. BlackRock Inc. boosted its stake in Stryker by 5.2% in the 2nd quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock worth $3,208,017,000 after purchasing an additional 1,139,082 shares during the period. Jensen Investment Management Inc. boosted its stake in Stryker by 11.3% in the 3rd quarter. Jensen Investment Management Inc. now owns 2,472,476 shares of the medical technology company’s stock worth $351,141,000 after purchasing an additional 251,685 shares during the period. Legal & General Group Plc boosted its stake in Stryker by 2.8% in the 3rd quarter. Legal & General Group Plc now owns 1,805,572 shares of the medical technology company’s stock worth $256,393,000 after purchasing an additional 49,143 shares during the period. Finally, Wells Fargo & Company MN boosted its stake in Stryker by 4.8% in the 3rd quarter. Wells Fargo & Company MN now owns 1,742,959 shares of the medical technology company’s stock worth $247,536,000 after purchasing an additional 79,551 shares during the period. 74.97% of the stock is owned by hedge funds and other institutional investors.

In related news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the transaction, the insider now owns 83,207 shares in the company, valued at approximately $12,925,375.38. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 7.40% of the stock is currently owned by corporate insiders.

A number of equities analysts recently weighed in on SYK shares. Robert W. Baird raised shares of Stryker from a “neutral” rating to an “outperform” rating and upped their target price for the stock from $161.00 to $173.00 in a research note on Thursday, November 16th. SunTrust Banks reissued a “buy” rating and set a $161.00 price target on shares of Stryker in a research report on Friday, November 17th. Wells Fargo & Company boosted their price target on shares of Stryker from $160.00 to $166.00 in a research report on Friday, October 27th. Barclays boosted their price target on shares of Stryker from $137.00 to $148.00 and gave the stock an “underweight” rating in a research report on Friday, October 27th. Finally, Oppenheimer reissued a “hold” rating on shares of Stryker in a research report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $152.10.

Shares of Stryker Corporation (SYK) traded down $0.61 during mid-day trading on Friday, hitting $151.15. 1,145,400 shares of the stock were exchanged, compared to its average volume of 1,180,981. Stryker Corporation has a 12 month low of $113.00 and a 12 month high of $160.62. The company has a market cap of $56,794.30, a PE ratio of 24.05, a price-to-earnings-growth ratio of 2.39 and a beta of 0.78. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, beating the Zacks’ consensus estimate of $1.50 by $0.02. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The business had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.97 billion. During the same quarter in the prior year, the business earned $1.39 EPS. Stryker’s quarterly revenue was up 6.1% on a year-over-year basis. research analysts anticipate that Stryker Corporation will post 6.47 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/08/chevy-chase-trust-holdings-inc-has-45-million-holdings-in-stryker-corporation-syk.html.

Stryker Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.